Remus Pharmaceuticals Ltd vs Vineet Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 705.75 as of 05 May 15:30 . The P/E Ratio of Remus Pharmaceuticals Ltd is 49.4 as of March 2024 .The P/E Ratio of Vineet Laboratories Ltd is 0 as of March 2024 . The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024 .The Market Cap of Vineet Laboratories Ltd is ₹ 0 crore as of March 2024 . The revenue of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vineet Laboratories Ltd for the Dec '25 is ₹ 15.7 crore as compare to the Sep '25 revenue of ₹ 17.43 crore. This represent the decline of -9.93% The ebitda of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vineet Laboratories Ltd for the Dec '25 is ₹ 2.54 crore as compare to the Sep '25 ebitda of ₹ 3.18 crore. This represent the decline of -20.13% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Vineet Laboratories Ltd changed from ₹ -2.13 crore to ₹ 0.85 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 yearsThe Dividend Payout of Vineet Laboratories Ltd changed from 13.89 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

About Vineet Laboratories Ltd

Vineet Laboratories Limited, formerly known as Ortin Laboratories Limited is a manufacturing company of intermediates useful for the manufacture of active pharmaceutical ingredients.
The Company was incorporated on 10 November 2016 and operates in the business of in the manufacture of Drug Intermediates & Bulk Dugs.
The name of the Company changed to Vineet Laboratories Limited, on account of demerger in December, 2020. The production unit located at Malkapur Village, Yadadri- Bhuvanagiri District in Telangana State, India, is a multipurpose facility well equipped with stainless steel and glass-lined reactors with total volume of 230KL, of different volumes to suit any batch size.
Special provisions are made to carry out reactions at very low temperature (up to -100°C).
The Company is also specialized in manufacturing and handling pyrophoric chemicals like n-Butyl Lithium.

FAQs for the comparison of Remus Pharmaceuticals Ltd and Vineet Laboratories Ltd

Which company has a larger market capitalization, Remus Pharmaceuticals Ltd or Vineet Laboratories Ltd?

Market cap of Remus Pharmaceuticals Ltd is 831 Cr while Market cap of Vineet Laboratories Ltd is 69 Cr

What are the key factors driving the stock performance of Remus Pharmaceuticals Ltd and Vineet Laboratories Ltd?

The stock performance of Remus Pharmaceuticals Ltd and Vineet Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remus Pharmaceuticals Ltd and Vineet Laboratories Ltd?

As of May 5, 2026, the Remus Pharmaceuticals Ltd stock price is INR ₹705.75. On the other hand, Vineet Laboratories Ltd stock price is INR ₹36.0.

How do dividend payouts of Remus Pharmaceuticals Ltd and Vineet Laboratories Ltd compare?

To compare the dividend payouts of Remus Pharmaceuticals Ltd and Vineet Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.